News
2025.04.22
Graph Therapeutics awarded Deep Tech Life Science Seed Financing Grant from the Austrian Wirtschaftsservice worth €1.1M
Graph has recieved the deep tech life sciences seed program grant from the funding from the Austria Wirtschaftsservice (AWS) to advance our clinically realistic precision immunology platform.
2025.03.28
Graph co-founder Berend Snijder appointed as Faculty Professor at the Botnar Institute of Immune Engineering
The Snijder lab specializes in systems oncology and immunology research. His group at the BIIE will continue to bridge biology with machine learning methods to further our understanding of molecular systems for medicine.
2025.03.03
Graph Therapeutics Awarded €1.1M "Austrian Life Sciences" FFG Grant
Graph has recieved grant funding from the Austrian Research Promotion Agency (FFG) to advance our clinically realistic precision immunology platform.
2025.01.09
Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases
Veteran techbio team that pioneered AI-driven precision oncology reunites to tackle the critical and complex challenges of inflammatory and immunological diseases